Quantcast

New Momentum By Medifast(TM) Product Line Tailored for Weight Loss Plateaus and Weight Maintenance

January 14, 2008

OWINGS MILLS, Md., Jan. 14 /PRNewswire-FirstCall/ — Medifast, Inc. , a leading portion-controlled weight loss program, today announced the launch of its new product line Momentum by Medifast, the first product line in the weight loss industry designed specifically to induce thermogenesis. Medifast also launched its new Super Omega-3 product today, the first dietary supplement to be added to the product line.

Momentum by Medifast is designed to burn extra calories, boost metabolism and decrease appetite, and has been clinically shown to have the maximum effect on inducing thermogenesis, making it ideal for clients in a weight loss plateau or the weight maintenance phase of the Medifast Program.

“Medifast is very excited to launch a product line tailored for weight loss plateaus and weight maintenance,” said Michael S. McDevitt, Chief Executive Officer, Medifast, Inc. “We fully expect Momentum by Medifast to enhance our clients’ success on the Medifast Program, keeping them motivated longer.”

Momentum by Medifast products contain 100 milligrams of caffeine and 90 milligrams of epigallocatechin gallate (EGCG), a potent antioxidant found in green tea. The combination of caffeine and EGCG found in three Momentum products has been clinically shown to increase the body’s metabolic rate above normal, which can result in burning extra calories.

“Our clinical study found that for two hours after consuming a Momentum product, energy expenditure increased by 24 percent,” said Lisa M. Davis, Ph.D., PA-C, C.N.S., L.D.N., Director of Research, Medifast, Inc. “This translates into burning an extra 60 to 100 calories per day. Momentum was designed as an excellent and effective tool for tackling plateaus and fostering weight maintenance.”

Momentum by Medifast features two types of products which are suitable for clients in all stages of the Medifast Program: meal replacements and a new product called a Flavor Infuser. Meal replacements are available in Banana Creme Shake, Cappuccino and Chai Latte flavors. Flavor Infusers are pencil paks containing individually packaged servings of flavored powder that can be added to water, and are available in Green Tea Lemon, Mixed Berry and Strawberry Lemonade flavors. Medifast clients can use any combination of Momentum by Medifast meal replacements and Flavor Infusers three times a day to produce the desired effects of thermogenesis.

Medifast’s Super Omega-3 supplements are enteric coated softgel capsules that offer Medifast clients organic flaxseed oil and the healthy fatty acids EPA and DHA. Medifast’s Super Omega-3 supplement supports healthy circulation; helps keep cholesterol levels in the normal, healthy range; helps maintain healthy blood pressure; helps support normal, healthy brain function; offers anti-inflammatory benefits and promotes lowered triglyceride levels. (As with most dietary supplements, these statements have not been evaluated by the Food and Drug Administration.)

“Medifast’s customized Super Omega-3 contains high concentrations of EPA and DHA in optimal proportions, plus organic flaxseed oil to enhance cardiovascular health and cognitive function, and improve the body’s anti- inflammatory response,” said Davis, co-author of the book, “Anti-Inflammatory Foods for Health”. “Its enteric coating ensures maximal bioavailability while reducing the fishy aftertaste often found with other brands. Recent studies now show that omega-3s also have the ability to reduce body fat. This feature makes Super Omega-3 the perfect complement to Medifast’s weight loss programs.”

   MED-G    About Medifast:  

Medifast is the leading easy-to-use, clinically proven portion-controlled weight loss program. Medifast has been recommended by 15,000 physicians and used by over one million customers. It is committed to enriching lives by providing innovative choices for lasting health. Medifast programs have been proven effective through studies by major university teaching hospitals. The company sells its products and programs via four unique distribution channels: 1) the web and national call centers, 2) national network of physicians, 3) medically supervised Medifast Weight Control Centers, and 4) the Take Shape For Life direct-selling division, a network of health coaches. Medifast was founded in 1980 and is located in Owings Mills, Maryland. For more information, log onto http://www.choosemedifast.com/.

Please Note: This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, Section 21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995. These forward-looking statements generally can be identified by use of phrases or terminology such as “intend” or other similar words or the negative of such terminology. Similarly, descriptions of Medifast’s objectives, strategies, plans, goals or targets contained herein are also considered forward-looking statements. Medifast believes this release should be read in conjunction with all of its filings with the United States Securities and Exchange Commission and cautions its readers that these forward-looking statements are subject to certain events, risks, uncertainties, and other factors. Some of these factors include, among others, Medifast’s inability to attract and retain independent Associates and Members, stability in the pricing of print, TV and Direct Mail marketing initiatives affecting the cost to acquire customers, increases in competition, litigation, regulatory changes, and its planned growth into new domestic and international markets and new channels of distribution. Although Medifast believes that the expectations, statements, and assumptions reflected in these forward-looking statements are reasonable, it cautions readers to always consider all of the risk factors and any other cautionary statements carefully in evaluating each forward-looking statement in this release, as well as those set forth in its latest Annual Report on Form 10-K and Quarterly Report on Form 10-Q, and other filings filed with the United States Securities and Exchange Commission, including its current reports on Form 8-K. All of the forward-looking statements contained herein speak only as of the date of this release.

Medifast, Inc.

CONTACT: Brian Gleason of Medifast, Inc., +1-410-504-8260,bgleason@choosemedifast.com

Web site: http://www.choosemedifast.com/




comments powered by Disqus